Showing results (1-10 of 39) with videos related to
Sort By:
Pageof 4
International Journal of Molecular Sciences|May 1, 2020
Can NF-κB Be Considered a Valid Drug Target in Neoplastic Diseases? Our Point of ViewManuela Labbozzetta, Monica Notarbartolo, Paola PomaCritical Reviews in Oncogenesis|August 4, 2021
Patterns of Innate or Acquired Resistance to Anticancer Drugs: Our Experience to Overcome ItPaola Poma, Manuela Labbozzetta, Monica NotarbartoloInternational Journal of Molecular Sciences|February 25, 2023
Natural Inhibitors of P-glycoprotein in Acute Myeloid LeukemiaManuela Labbozzetta, Paola Poma, Monica NotarbartoloOmics : a Journal of Integrative Biology|April 8, 2017
NF-κB Is a Potential Molecular Drug Target in Triple-Negative Breast CancersPaola Poma, Manuela Labbozzetta, Natale D'Alessandro, et al.Molecules (Basel, Switzerland)|July 9, 2022
Antitumor Effect of <i>Glandora rosmarinifolia</i> (Boraginaceae) Essential Oil through Inhibition of the Activity of the Topo II Enzyme in Acute Myeloid LeukemiaManuela Labbozzetta, Paola Poma, Chiara Occhipinti, et al.Current Molecular Medicine|January 5, 2019
Potential Therapeutic Applications of MDA-9/Syntenin-NF-κB-RKIP Loop in Human Liver CarcinomaMonica Notarbartolo, Manuela Labbozzetta, Fanny Pojero, et al.Plos One|March 29, 2019
Essential oil of Cyphostemma juttae (Vitaceae): Chemical composition and antitumor mechanism in triple negative breast cancer cellsPietro Zito, Manuela Labbozzetta, Monica Notarbartolo, et al.Oncology Letters|January 21, 2016
Epigenetic changes and nuclear factor-κB activation, but not microRNA-224, downregulate Raf-1 kinase inhibitor protein in triple-negative breast cancer SUM 159 cellsManuela Labbozzetta, Paola Poma, Nicoletta Vivona, et al.Omics : a Journal of Integrative Biology|October 26, 2012
Analysis of possible mechanisms accounting for raf-1 kinase inhibitor protein downregulation in hepatocellular carcinomaPaola Poma, Manuela Labbozzetta, Nicoletta Vivona, et al.Pharmaceuticals (Basel, Switzerland)|March 26, 2022
Phytol and Heptacosane Are Possible Tools to Overcome Multidrug Resistance in an In Vitro Model of Acute Myeloid LeukemiaManuela Labbozzetta, Paola Poma, Marco Tutone, et al.Pageof 4